Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials-Reference-Cited by-同舟云学术

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Published:2010-02 Issue:9716 Volume:375 Page:735-742
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sattar Naveed,Preiss David,Murray Heather M,Welsh Paul,Buckley Brendan M,de Craen Anton JM,Seshasai Sreenivasa Rao Kondapally,McMurray John J,Freeman Dilys J,Jukema J Wouter,Macfarlane Peter W,Packard Chris J,Stott David J,Westendorp Rudi G,Shepherd James,Davis Barry R,Pressel Sara L,Marchioli Roberto,Marfisi Rosa Maria,Maggioni Aldo P,Tavazzi Luigi,Tognoni Gianni,Kjekshus John,Pedersen Terje R,Cook Thomas J,Gotto Antonio M,Clearfield Michael B,Downs John R,Nakamura Haruo,Ohashi Yasuo,Mizuno Kyoichi,Ray Kausik K,Ford Ian

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins;Lancet,2005

2. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis;Lancet,2008

3. The safety of statins in clinical practice;Armitage;Lancet,2007

4. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N Engl J Med,2008

5. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study;Freeman;Circulation,2001

Cited by 2033 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-course atherogenic blood lipid response to statin discontinuation in dyslipidemic adults;Nutrition, Metabolism and Cardiovascular Diseases;2024-10

2. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12

3. Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12

4. Low LDL-C: Is It all Good News?;Current Atherosclerosis Reports;2024-09-10

5. Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study;Heart;2024-09-10